Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASTER-ED
NCT02498496Phase 4Withdrawn
- Sponsor
- Hôpital de Verdun
- Start
- Sep 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD), sponsored by Hôpital de Verdun. Planned start Sep 2016; status: withdrawn.
02
Drugs
magnesium sulfate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02498496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02498496.